Velcade Side Effects
Post Side Effect
Ask Community
Compare Side Effects
Post Your Velcade Experience:
Velcade Side Effects Report #5199966-4
Physician from UNITED STATES reported Velcade side effect on Dec 19, 2006. Female patient was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, hypercalcaemia, pneumonia
, respiratory failure. Velcade dosage: 1.30 MG/M2, IV BOLUS. Patient died.
Velcade Side Effects Report #5199974-3
Velcade side effect was reported by a Physician from UNITED STATES on Dec 18, 2006. Male patient, 52 years of age, was diagnosed with mantle cell lymphoma stage iv and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematuria, hydronephrosis, hyperkalaemia, nausea, oral intake reduced, prostatitis, pyelonephritis, renal failure acute, tumour lysis syndrome. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BACTRIM, VALTREX, ARANESP. Patient was hospitalized.
Physician from UNITED STATES reported Velcade side effect on Dec 19, 2006. Female patient was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, hypercalcaemia, pneumonia
, respiratory failure. Velcade dosage: 1.30 MG/M2, IV BOLUS. Patient died.
Velcade Side Effects Report #5199974-3
Velcade side effect was reported by a Physician from UNITED STATES on Dec 18, 2006. Male patient, 52 years of age, was diagnosed with mantle cell lymphoma stage iv and was treated with Velcade. After drug was administered, patient experienced the following side effects: haematuria, hydronephrosis, hyperkalaemia, nausea
, oral intake reduced, prostatitis, pyelonephritis, renal failure acute, tumour lysis syndrome. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BACTRIM, VALTREX, ARANESP. Patient was hospitalized. View More
View All Velcade FDA Adverse ReportsVelcade Side Effects
Go to the top of the page
Velcade Questions
Ask Community about Velcade:
Comments to date: 1. Page 1 of 1.
Ryan Location unknown | 2:45am on Thursday, December 4th, 2008 |
Just completed 6 cycles of velcade for relapsed multiple myeloma. I had severe leg pains which kept... read more » | |
Ask Community about Velcade:
What is Your Question? Ask Community:
Velcade Adverse Effect Reports (FDA)
Physician from FRANCE reported Velcade side effect on Dec 19, 2006. Male patient, 61 years of age, weighting 189.6 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: hyponatraemia, inappropriate antidiuretic hormone secretion. Velcade dosage: 3.00 MG. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXIL, VINCRISTINE. Patient was hospitalized.
Velcade Side Effects Report #5201100-9
Velcade side effect was reported by a Physician from CANADA on Dec 19, 2006. Male patient, 38 years of age, weighting 267.9 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure increased, disease progression, electrocardiogram t wave biphasic, pneumonia , pulmonary embolism , sepsis , sinus tachycardia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized.
Velcade Side Effects Report #5201279-9
Physician from FRANCE reported Velcade side effect on Dec 19, 2006. Male patient, 41 years of age, weighting 152.1 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: pneumocystis jiroveci pneumonia. Velcade dosage: 2.81 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, BLEOMYCIN, METHOTREXATE, PREDNISONE, BACTRIM. Patient was hospitalized.
Velcade Side Effects Report #5201283-0
Velcade side effect was reported by a Physician from FRANCE on Dec 19, 2006. Male patient, 87 years of age, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute abdomen, body temperature increased, faecaloma, septic shock, urinary retention. Velcade dosage: 1.50 MG/M2, INTRAVENOUS. During the same period patient was treated with ARACYTINE. Patient was hospitalized. Patient died on 09/25/2006.
Velcade Side Effects Report #5201627-X
Physician from RUSSIAN FEDERATION reported Velcade side effect on Dec 20, 2006. Female patient, 57 years of age, weighting 202.8 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatitis b , transaminases increased. Velcade dosage: 3.50 MG, INTRAVENOUS. Patient was hospitalized.
Velcade Side Effects Report #5201871-1
Velcade side effect was reported by a Physician from NETHERLANDS on Dec 21, 2006. Female patient, 59 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: encephalitis herpes, hepatitis viral, herpes virus infection. Velcade dosage: unknown. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, MELPHALAN, OMEPRAZOLE, MORPHINE.
Velcade Side Effects Report #5201877-2
Physician from FRANCE reported Velcade side effect on Dec 21, 2006. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: photosensitivity reaction, skin hyperpigmentation. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, BLEOMYCIN, PREDNISONE, GRANOCYTE.
Velcade Side Effects Report #5201878-4
Velcade side effect was reported by a Physician from ITALY on Dec 21, 2006. Male patient, 63 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: bundle branch block left, fall , head injury, syncope. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized.
Velcade Side Effects Report #5201888-7
Physician from SPAIN reported Velcade side effect on Dec 20, 2006. Male patient was treated with Velcade. After drug was administered, patient experienced the following side effects: hepatotoxicity, transaminases increased. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE.
Velcade Side Effects Report #5201894-2
Velcade side effect was reported by a Physician from FRANCE on Dec 20, 2006. Male patient, 59 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemophilus infection. Velcade dosage: 2.60 MG. Patient was hospitalized.
Velcade Side Effects Report #5201897-8
Physician from FRANCE reported Velcade side effect on Dec 20, 2006. Female patient, 65 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: fungal infection , haemoglobin decreased, hyperthermia, hypoxia, influenza like illness, lung disorder, platelet count increased, productive cough, pulmonary fibrosis . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OMEPRAZOLE, MORPHINE SULPHATE, PARACETAMOL, LORAZEPAM. Patient was hospitalized.
Velcade Side Effects Report #5201903-0
Velcade side effect was reported by a Physician from RUSSIAN FEDERATION on Dec 20, 2006. Male patient, 66 years of age, weighting 187.4 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , gastrointestinal motility disorder. Velcade dosage: 2.60 MG, INTRAVENOUS. Patient was hospitalized.
Velcade Side Effects Report #5201905-4
Health Professional from UNITED KINGDOM reported Velcade side effect on Dec 20, 2006. Male patient, 63 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , circulatory collapse, fall , hypotension, lethargy. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with OMEPRAZOLE, CIPROFLOXACIN, TAMSULOSIN, SALBUTAMOL INHALANT, SERETIDE, ZOFRAN, VITAMIN BLET, PYRIDOXINE. Patient was hospitalized.
Velcade Side Effects Report #5203384-X
Velcade side effect was reported by a Physician from JAPAN on Dec 26, 2006. Female patient, 64 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure decreased, cyanosis. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 12/26/2006.
Velcade Side Effects Report #5203398-X
Physician from JAPAN reported Velcade side effect on Dec 26, 2006. Male patient, 71 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspergillosis, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, febrile neutropenia, hyperkalaemia, hypocalcaemia, pleural effusion. Velcade dosage: 1.40 MG/M2, INTRAVENOUS. During the same period patient was treated with GAMIMUNE.
Velcade Side Effects Report #5203399-1
Velcade side effect was reported by a Physician from JAPAN on Dec 26, 2006. Male patient, 70 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium abnormal, gastric haemorrhage, oesophageal haemorrhage, pancytopenia, pyrexia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 12/26/2006.
Velcade Side Effects Report #5203416-9
Physician from JAPAN reported Velcade side effect on Dec 27, 2006. Male patient, 64 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: cryptogenic organising pneumonia, lung injury, sepsis . Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. Patient died.
Velcade Side Effects Report #5203446-7
Velcade side effect was reported by a Physician from AUSTRALIA on Dec 27, 2006. Female patient, 60 years of age, weighting 211.6 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: hepatitis , pulmonary embolism , thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, GLIMEPIRIDE, METFORMIN, CLODRONATE DI, SIMVASTATIN, PROTAPHANE MC. Patient was hospitalized and became disabled.
Velcade Side Effects Report #5203475-3
Physician from AUSTRALIA reported Velcade side effect on Dec 27, 2006. Female patient, 76 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, atrial fibrillation , cardiac failure, condition aggravated, confusional state, constipation , diarrhoea, dyspnoea, fatigue. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MS CONTIN. Patient was hospitalized.
Velcade Side Effects Report #5203480-7
Velcade side effect was reported by a Consumer or non-health professional from SPAIN on Dec 27, 2006. Male patient, 75 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, neuropathy peripheral, spontaneous haematoma. Velcade dosage: 3.50 MG UNK. During the same period patient was treated with UNIKET, NORVASC, PAROXETINE, OMEPRAZOLE, SUMIAL, ALOPURINOL, NEURONTIN, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient died on 11/20/2006.
Velcade Side Effects Report #5203481-9
Physician from GERMANY reported Velcade side effect on Dec 22, 2006. Male patient, 69 years of age, weighting 211.6 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute hepatic failure, blood albumin decreased, prothrombin time prolonged. Velcade dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, ACETAMINOPHEN, MORPHINE. Patient was hospitalized.
Velcade Side Effects Report #5203622-3
Velcade side effect was reported by a Physician from UNITED STATES on Dec 22, 2006. Male patient, 68 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection, blood albumin decreased, blood glucose increased, blood lactate dehydrogenase increased, cryoglobulinaemia, culture positive, enterococcal infection. Velcade dosage: unknown. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, INSULIN. Patient was hospitalized.
Velcade Side Effects Report #5203839-8
Physician from UNITED STATES reported Velcade side effect on Dec 22, 2006. Male patient, 57 years of age, weighting 144.2 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, decreased appetite, deep vein thrombosis , hypokalaemia, iiird nerve paralysis, meningitis cryptococcal, neuralgia, neuropathy peripheral. Velcade dosage: 1.30 MG/M2, INTRAVENOUS; 1.70 MG, INTRAVENOUS. During the same period patient was treated with ALOXI, ZOMETA, ARANESP, PHENERGAN, EMLA CREAM, DIFLUCAN. Patient was hospitalized and became disabled.
Velcade Side Effects Report #5203929-X
Velcade side effect was reported by a Physician from UNITED STATES on Dec 22, 2006. Male patient, 69 years of age, was diagnosed with mantle cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: chills, infusion related reaction, nausea, pruritus, pyrexia, urticaria. Velcade dosage: unknown. During the same period patient was treated with RITUXIMAB, VINCRISTINE, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, DIOVAN HCT, SINGULAIR. Patient was hospitalized.
Velcade Side Effects Report #5203932-X
Physician from UNITED STATES reported Velcade side effect on Dec 27, 2006. Male patient, 66 years of age, weighting 192.9 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: calcinosis, dyspnoea, electrocardiogram st-t change, hyperhidrosis, hypertrophic cardiomyopathy, hypotension, lung neoplasm, sepsis , stem cell transplant. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized.
Velcade Side Effects Report #5203969-0
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Dec 27, 2006. Male patient, 63 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , circulatory collapse, fall , hypotension, lethargy, malaise, neutropenia. Velcade dosage: 1.30 MG/MD, INTRAVENOUS. During the same period patient was treated with OMEPRAZOLE, CIPROFLOXACIN, TAMSULOSIN, SALBUTAMOL INHALANT, SERETIDE, ZOFRAN, VITAMIN BLET, PYRIDOXINE. Patient was hospitalized.
Velcade Side Effects Report #5203974-4
Physician from AUSTRALIA reported Velcade side effect on Dec 22, 2006. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: pneumonia . Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ENOXAPARIN, ALODORM, LOSEC, MIRTAZAPINE, PERIACTIN, ACETAMINOPHEN, TRAMADOL. Patient was hospitalized. Patient died on 12/17/2006.
Velcade Side Effects Report #5203976-8
Velcade side effect was reported by a Physician from THAILAND on Dec 22, 2006. Male patient, 63 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: endocarditis , staphylococcal infection , thrombophlebitis. Velcade dosage: unknown. Patient was hospitalized.
Velcade Side Effects Report #5203982-3
Physician from FRANCE reported Velcade side effect on Dec 27, 2006. Male patient, 64 years of age, weighting 180.8 lb, was diagnosed with b-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: toxic skin eruption. Velcade dosage: 3.00 MG, INTRAVENOUS. During the same period patient was treated with CEFIXIME CHEWABLE, CIPROFLOXACIN, ALLOPURINOL, BACTRIM, FOLIC ACID, ACETAMINOPHEN, METRONIDAZOLE, LOPERAMIDE.
Velcade Side Effects Report #5206641-6
Velcade side effect was reported by a Physician from GERMANY on Dec 28, 2006. Female patient, 55 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , musculoskeletal pain, neck pain, pyrexia. Velcade dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, DEXAMETHASONE. Patient was hospitalized.
Velcade Side Effects Report #5206645-3
Physician from BELGIUM reported Velcade side effect on Dec 29, 2006. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, pulmonary embolism. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with ALIMTA. Patient was hospitalized.
Velcade Side Effects Report #5206647-7
Velcade side effect was reported by a Physician from JAPAN on Dec 28, 2006. Female patient, 64 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: arterial thrombosis limb, blood pressure decreased, cyanosis, hypoxia, myocardial infarction, necrosis. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 12/26/2006.
Velcade Side Effects Report #5206648-9
Physician from FRANCE reported Velcade side effect on Jan 04, 2007. Male patient, 59 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemophilus infection. Velcade dosage: 2.60 MG. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized.
Velcade Side Effects Report #5206660-X
Velcade side effect was reported by a Physician from FRANCE on Jan 03, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood culture positive, catheter related infection, diabetes mellitus inadequate control. Velcade dosage: 3.33 MG, INTRAVENOUS. During the same period patient was treated with INSULIN. Patient was hospitalized.
Velcade Side Effects Report #5206863-4
Physician from JAPAN reported Velcade side effect on Dec 27, 2006. Female patient, 31 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, interstitial lung disease, lung injury, pleural effusion, respiratory failure. Velcade dosage: 1.30 MG/M2. Patient died.
Velcade Side Effects Report #5207049-X
Velcade side effect was reported by a Physician from UNITED STATES on Dec 29, 2006. Male patient, 57 years of age, weighting 144.2 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, breakthrough pain, decreased appetite, deep vein thrombosis , eyelid ptosis, fatigue, hypokalaemia, iiird nerve paralysis, neuralgia. Velcade dosage: unknown. During the same period patient was treated with ALOXI, ZOMETA, ARANESP, PHENERGAN, EMLA CREAM, DIFLUCAN.
Velcade Side Effects Report #5207337-7
Physician from ITALY reported Velcade side effect on Jan 04, 2007. Male patient, 70 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, intracranial aneurysm. Velcade dosage: 2.40 MG, UNK,. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient died on 12/30/2006.
Velcade Side Effects Report #5207987-8
Velcade side effect was reported by a Physician from FRANCE on Dec 29, 2006. Female patient, 56 years of age, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: aplasia, oesophageal candidiasis. Velcade dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, METHOTREXATE, MESNA, GRANOCYTE. Patient was hospitalized.
Velcade Side Effects Report #5208874-1
Health Professional from UNITED STATES reported Velcade side effect on Jan 11, 2007. Male patient, weighting 280.9 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: agitation, convulsion, delirium, disease progression, dyskinesia, dyspnoea, encephalopathy, haemorrhage, hypoxia. Velcade dosage: 1.3 MG/M2 DAYS 1, 4, 8 AND 11 IV. During the same period patient was treated with DOXORUBICIN, KEPPRA, ACYCLOVIR, ALLOPURINOL, DEXAMETHASONE, DOLASENTRON, MOXIFLOXACIN, PANTOPRAZOLE. Patient died on 12/19/2006.
Velcade Side Effects Report #5209650-6
Velcade side effect was reported by a Physician from FRANCE on Jan 03, 2007. Male patient, 74 years of age, weighting 154.3 lb, was diagnosed with mantle cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac arrest, myocardial infarction. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 11/18/2006.
Velcade Side Effects Report #5211384-9
Physician from UNITED STATES reported Velcade side effect on Jan 02, 2007. Female patient, 55 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: dermatitis, pyrexia. Velcade dosage: unknown. Patient was hospitalized.
Velcade Side Effects Report #5213000-9
Velcade side effect was reported by a Physician from JAPAN on Jan 04, 2007. Male patient, 60 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hyperkalaemia, hyperuricaemia, neuropathy peripheral, platelet count decreased, tumour lysis syndrome. Velcade dosage: 1.90 MG, UNK; UNK. During the same period patient was treated with ALBUMIN, DEXAMETHASONE, MUCOSTA, ZANTAC, SULFAMETHOXAZOLE, DIFLUCAN, BIOFERMIN R, ZOVIRAX.
Velcade Side Effects Report #5213008-3
Physician from FRANCE reported Velcade side effect on Jan 04, 2007. Male patient, 47 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, acute respiratory distress syndrome, aortic valve disease, cardiac failure acute, chills, condition aggravated, ejection fraction decreased, hypovolaemia, interstitial lung disease. Velcade dosage: 2.60 MG, UNK; INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FLECAINIDE ACETATE, FENOFIBRATE, ALLOPURINOL, BACTRIM, VALACYCLOVIR. Patient was hospitalized.
Velcade Side Effects Report #5214194-1
Velcade side effect was reported by a Physician from UNITED STATES on Jan 03, 2007. Male patient, 82 years of age, weighting 173.1 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, chronic obstructive pulmonary disease, hyperlipidaemia, mental status changes, multiple myeloma , pancytopenia, renal failure acute, respiratory failure. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, ASCORBIC ACID. Patient was hospitalized. Patient died on 11/18/2006.
Velcade Side Effects Report #5214325-3
Physician from UNITED STATES reported Velcade side effect on Dec 11, 2006. Male patient was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: dehydration, hypoxia, interstitial lung disease, lung infiltration, pyrexia, respiratory distress. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with INSULIN. Patient was hospitalized.
Velcade Side Effects Report #5214690-7
Velcade side effect was reported by a Physician from FRANCE on Jan 04, 2007. Male patient, 64 years of age, weighting 152.1 lb, was diagnosed with b-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: diffuse alveolar damage, herpes zoster, hypercalcaemia, interstitial lung disease, lung disorder, lung infection, malignant neoplasm progression, non-hodgkin's lymphoma. Velcade dosage: 2.90 MG, INTRAVENOUS. During the same period patient was treated with TINZAPARIN, RAMIPRIL, ALLOPURINOL. Patient was hospitalized.
Velcade Side Effects Report #5214696-8
Physician from BELGIUM reported Velcade side effect on Jan 04, 2007. Male patient, 56 years of age, weighting 204.1 lb, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchitis , bursitis , lymphopenia, palmar-plantar erythrodysaesthesia syndrome. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXIL, TEGRETOL, CARDIO ASPIRINA, ZANTAC, DEXCHLORPHENIRAMINE MALEATE, LITICAN. Patient was hospitalized.
Velcade Side Effects Report #5214702-0
Velcade side effect was reported by a Physician from GERMANY on Jan 11, 2007. Female patient, 76 years of age, was diagnosed with multiple myeloma and was treated with Velcade. After drug was administered, patient experienced the following side effects: multiple myeloma . Velcade dosage: 1.30 MG. Patient died on 11/12/2006.
Go to the top of the page
Showing 1-50 of 5712 Next >
Velcade Side Effects Report #5201097-1Physician from FRANCE reported Velcade side effect on Dec 19, 2006. Male patient, 61 years of age, weighting 189.6 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: hyponatraemia, inappropriate antidiuretic hormone secretion. Velcade dosage: 3.00 MG. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXIL, VINCRISTINE. Patient was hospitalized.
Velcade Side Effects Report #5201100-9
Velcade side effect was reported by a Physician from CANADA on Dec 19, 2006. Male patient, 38 years of age, weighting 267.9 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure increased, disease progression, electrocardiogram t wave biphasic, pneumonia , pulmonary embolism , sepsis , sinus tachycardia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized. Velcade Side Effects Report #5201279-9
Physician from FRANCE reported Velcade side effect on Dec 19, 2006. Male patient, 41 years of age, weighting 152.1 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: pneumocystis jiroveci pneumonia. Velcade dosage: 2.81 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, BLEOMYCIN, METHOTREXATE, PREDNISONE, BACTRIM. Patient was hospitalized.
Velcade Side Effects Report #5201283-0
Velcade side effect was reported by a Physician from FRANCE on Dec 19, 2006. Male patient, 87 years of age, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute abdomen, body temperature increased, faecaloma, septic shock, urinary retention. Velcade dosage: 1.50 MG/M2, INTRAVENOUS. During the same period patient was treated with ARACYTINE. Patient was hospitalized. Patient died on 09/25/2006.
Velcade Side Effects Report #5201627-X
Physician from RUSSIAN FEDERATION reported Velcade side effect on Dec 20, 2006. Female patient, 57 years of age, weighting 202.8 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatitis b , transaminases increased. Velcade dosage: 3.50 MG, INTRAVENOUS. Patient was hospitalized. Velcade Side Effects Report #5201871-1
Velcade side effect was reported by a Physician from NETHERLANDS on Dec 21, 2006. Female patient, 59 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: encephalitis herpes, hepatitis viral, herpes virus infection. Velcade dosage: unknown. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, MELPHALAN, OMEPRAZOLE, MORPHINE. Velcade Side Effects Report #5201877-2
Physician from FRANCE reported Velcade side effect on Dec 21, 2006. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: photosensitivity reaction, skin hyperpigmentation. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, BLEOMYCIN, PREDNISONE, GRANOCYTE.
Velcade Side Effects Report #5201878-4
Velcade side effect was reported by a Physician from ITALY on Dec 21, 2006. Male patient, 63 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: bundle branch block left, fall , head injury, syncope. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Velcade Side Effects Report #5201888-7
Physician from SPAIN reported Velcade side effect on Dec 20, 2006. Male patient was treated with Velcade. After drug was administered, patient experienced the following side effects: hepatotoxicity, transaminases increased. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE.
Velcade Side Effects Report #5201894-2
Velcade side effect was reported by a Physician from FRANCE on Dec 20, 2006. Male patient, 59 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemophilus infection. Velcade dosage: 2.60 MG. Patient was hospitalized. Velcade Side Effects Report #5201897-8
Physician from FRANCE reported Velcade side effect on Dec 20, 2006. Female patient, 65 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: fungal infection , haemoglobin decreased, hyperthermia, hypoxia, influenza like illness, lung disorder, platelet count increased, productive cough, pulmonary fibrosis . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OMEPRAZOLE, MORPHINE SULPHATE, PARACETAMOL, LORAZEPAM. Patient was hospitalized. Velcade Side Effects Report #5201903-0
Velcade side effect was reported by a Physician from RUSSIAN FEDERATION on Dec 20, 2006. Male patient, 66 years of age, weighting 187.4 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , gastrointestinal motility disorder. Velcade dosage: 2.60 MG, INTRAVENOUS. Patient was hospitalized. Velcade Side Effects Report #5201905-4
Health Professional from UNITED KINGDOM reported Velcade side effect on Dec 20, 2006. Male patient, 63 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , circulatory collapse, fall , hypotension, lethargy. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with OMEPRAZOLE, CIPROFLOXACIN, TAMSULOSIN, SALBUTAMOL INHALANT, SERETIDE, ZOFRAN, VITAMIN BLET, PYRIDOXINE. Patient was hospitalized. Velcade Side Effects Report #5203384-X
Velcade side effect was reported by a Physician from JAPAN on Dec 26, 2006. Female patient, 64 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure decreased, cyanosis. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 12/26/2006.Velcade Side Effects Report #5203398-X
Physician from JAPAN reported Velcade side effect on Dec 26, 2006. Male patient, 71 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspergillosis, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, febrile neutropenia, hyperkalaemia, hypocalcaemia, pleural effusion. Velcade dosage: 1.40 MG/M2, INTRAVENOUS. During the same period patient was treated with GAMIMUNE. Velcade Side Effects Report #5203399-1
Velcade side effect was reported by a Physician from JAPAN on Dec 26, 2006. Male patient, 70 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium abnormal, gastric haemorrhage, oesophageal haemorrhage, pancytopenia, pyrexia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 12/26/2006.Velcade Side Effects Report #5203416-9
Physician from JAPAN reported Velcade side effect on Dec 27, 2006. Male patient, 64 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: cryptogenic organising pneumonia, lung injury, sepsis . Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. Patient died.Velcade Side Effects Report #5203446-7
Velcade side effect was reported by a Physician from AUSTRALIA on Dec 27, 2006. Female patient, 60 years of age, weighting 211.6 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: hepatitis , pulmonary embolism , thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, GLIMEPIRIDE, METFORMIN, CLODRONATE DI, SIMVASTATIN, PROTAPHANE MC. Patient was hospitalized and became disabled. Velcade Side Effects Report #5203475-3
Physician from AUSTRALIA reported Velcade side effect on Dec 27, 2006. Female patient, 76 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, atrial fibrillation , cardiac failure, condition aggravated, confusional state, constipation , diarrhoea, dyspnoea, fatigue. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MS CONTIN. Patient was hospitalized. Velcade Side Effects Report #5203480-7
Velcade side effect was reported by a Consumer or non-health professional from SPAIN on Dec 27, 2006. Male patient, 75 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, neuropathy peripheral, spontaneous haematoma. Velcade dosage: 3.50 MG UNK. During the same period patient was treated with UNIKET, NORVASC, PAROXETINE, OMEPRAZOLE, SUMIAL, ALOPURINOL, NEURONTIN, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient died on 11/20/2006.Velcade Side Effects Report #5203481-9
Physician from GERMANY reported Velcade side effect on Dec 22, 2006. Male patient, 69 years of age, weighting 211.6 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute hepatic failure, blood albumin decreased, prothrombin time prolonged. Velcade dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, ACETAMINOPHEN, MORPHINE. Patient was hospitalized. Velcade Side Effects Report #5203622-3
Velcade side effect was reported by a Physician from UNITED STATES on Dec 22, 2006. Male patient, 68 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection
, blood albumin decreased, blood glucose increased, blood lactate dehydrogenase increased, cryoglobulinaemia, culture positive, enterococcal infection. Velcade dosage: unknown. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, INSULIN. Patient was hospitalized. Velcade Side Effects Report #5203839-8
Physician from UNITED STATES reported Velcade side effect on Dec 22, 2006. Male patient, 57 years of age, weighting 144.2 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, decreased appetite, deep vein thrombosis , hypokalaemia, iiird nerve paralysis, meningitis cryptococcal, neuralgia, neuropathy peripheral. Velcade dosage: 1.30 MG/M2, INTRAVENOUS; 1.70 MG, INTRAVENOUS. During the same period patient was treated with ALOXI, ZOMETA, ARANESP, PHENERGAN, EMLA CREAM, DIFLUCAN. Patient was hospitalized and became disabled. Velcade Side Effects Report #5203929-X
Velcade side effect was reported by a Physician from UNITED STATES on Dec 22, 2006. Male patient, 69 years of age, was diagnosed with mantle cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: chills, infusion related reaction, nausea
, pruritus, pyrexia, urticaria. Velcade dosage: unknown. During the same period patient was treated with RITUXIMAB, VINCRISTINE, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, DIOVAN HCT, SINGULAIR. Patient was hospitalized. Velcade Side Effects Report #5203932-X
Physician from UNITED STATES reported Velcade side effect on Dec 27, 2006. Male patient, 66 years of age, weighting 192.9 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: calcinosis, dyspnoea, electrocardiogram st-t change, hyperhidrosis, hypertrophic cardiomyopathy, hypotension, lung neoplasm, sepsis , stem cell transplant. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Velcade Side Effects Report #5203969-0
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Dec 27, 2006. Male patient, 63 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , circulatory collapse, fall , hypotension, lethargy, malaise, neutropenia. Velcade dosage: 1.30 MG/MD, INTRAVENOUS. During the same period patient was treated with OMEPRAZOLE, CIPROFLOXACIN, TAMSULOSIN, SALBUTAMOL INHALANT, SERETIDE, ZOFRAN, VITAMIN BLET, PYRIDOXINE. Patient was hospitalized. Velcade Side Effects Report #5203974-4
Physician from AUSTRALIA reported Velcade side effect on Dec 22, 2006. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: pneumonia . Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ENOXAPARIN, ALODORM, LOSEC, MIRTAZAPINE, PERIACTIN, ACETAMINOPHEN, TRAMADOL. Patient was hospitalized. Patient died on 12/17/2006.Velcade Side Effects Report #5203976-8
Velcade side effect was reported by a Physician from THAILAND on Dec 22, 2006. Male patient, 63 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: endocarditis , staphylococcal infection , thrombophlebitis. Velcade dosage: unknown. Patient was hospitalized. Velcade Side Effects Report #5203982-3
Physician from FRANCE reported Velcade side effect on Dec 27, 2006. Male patient, 64 years of age, weighting 180.8 lb, was diagnosed with b-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: toxic skin eruption. Velcade dosage: 3.00 MG, INTRAVENOUS. During the same period patient was treated with CEFIXIME CHEWABLE, CIPROFLOXACIN, ALLOPURINOL, BACTRIM, FOLIC ACID, ACETAMINOPHEN, METRONIDAZOLE, LOPERAMIDE.
Velcade Side Effects Report #5206641-6
Velcade side effect was reported by a Physician from GERMANY on Dec 28, 2006. Female patient, 55 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , musculoskeletal pain, neck pain, pyrexia. Velcade dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, DEXAMETHASONE. Patient was hospitalized. Velcade Side Effects Report #5206645-3
Physician from BELGIUM reported Velcade side effect on Dec 29, 2006. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, pulmonary embolism
. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with ALIMTA. Patient was hospitalized. Velcade Side Effects Report #5206647-7
Velcade side effect was reported by a Physician from JAPAN on Dec 28, 2006. Female patient, 64 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: arterial thrombosis limb, blood pressure decreased, cyanosis, hypoxia, myocardial infarction, necrosis. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 12/26/2006.Velcade Side Effects Report #5206648-9
Physician from FRANCE reported Velcade side effect on Jan 04, 2007. Male patient, 59 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemophilus infection. Velcade dosage: 2.60 MG. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Velcade Side Effects Report #5206660-X
Velcade side effect was reported by a Physician from FRANCE on Jan 03, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood culture positive, catheter related infection, diabetes mellitus inadequate control. Velcade dosage: 3.33 MG, INTRAVENOUS. During the same period patient was treated with INSULIN. Patient was hospitalized.
Velcade Side Effects Report #5206863-4
Physician from JAPAN reported Velcade side effect on Dec 27, 2006. Female patient, 31 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, interstitial lung disease, lung injury, pleural effusion, respiratory failure. Velcade dosage: 1.30 MG/M2. Patient died.Velcade Side Effects Report #5207049-X
Velcade side effect was reported by a Physician from UNITED STATES on Dec 29, 2006. Male patient, 57 years of age, weighting 144.2 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, breakthrough pain, decreased appetite, deep vein thrombosis , eyelid ptosis, fatigue, hypokalaemia, iiird nerve paralysis, neuralgia. Velcade dosage: unknown. During the same period patient was treated with ALOXI, ZOMETA, ARANESP, PHENERGAN, EMLA CREAM, DIFLUCAN. Velcade Side Effects Report #5207337-7
Physician from ITALY reported Velcade side effect on Jan 04, 2007. Male patient, 70 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, intracranial aneurysm. Velcade dosage: 2.40 MG, UNK,. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient died on 12/30/2006.Velcade Side Effects Report #5207987-8
Velcade side effect was reported by a Physician from FRANCE on Dec 29, 2006. Female patient, 56 years of age, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: aplasia, oesophageal candidiasis. Velcade dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, METHOTREXATE, MESNA, GRANOCYTE. Patient was hospitalized.
Velcade Side Effects Report #5208874-1
Health Professional from UNITED STATES reported Velcade side effect on Jan 11, 2007. Male patient, weighting 280.9 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: agitation, convulsion, delirium, disease progression, dyskinesia, dyspnoea, encephalopathy, haemorrhage, hypoxia. Velcade dosage: 1.3 MG/M2 DAYS 1, 4, 8 AND 11 IV. During the same period patient was treated with DOXORUBICIN, KEPPRA, ACYCLOVIR, ALLOPURINOL, DEXAMETHASONE, DOLASENTRON, MOXIFLOXACIN, PANTOPRAZOLE. Patient died on 12/19/2006.Velcade Side Effects Report #5209650-6
Velcade side effect was reported by a Physician from FRANCE on Jan 03, 2007. Male patient, 74 years of age, weighting 154.3 lb, was diagnosed with mantle cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac arrest
, myocardial infarction. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 11/18/2006.Velcade Side Effects Report #5211384-9
Physician from UNITED STATES reported Velcade side effect on Jan 02, 2007. Female patient, 55 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: dermatitis, pyrexia. Velcade dosage: unknown. Patient was hospitalized. Velcade Side Effects Report #5213000-9
Velcade side effect was reported by a Physician from JAPAN on Jan 04, 2007. Male patient, 60 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hyperkalaemia, hyperuricaemia, neuropathy peripheral, platelet count decreased, tumour lysis syndrome. Velcade dosage: 1.90 MG, UNK; UNK. During the same period patient was treated with ALBUMIN, DEXAMETHASONE, MUCOSTA, ZANTAC, SULFAMETHOXAZOLE, DIFLUCAN, BIOFERMIN R, ZOVIRAX. Velcade Side Effects Report #5213008-3
Physician from FRANCE reported Velcade side effect on Jan 04, 2007. Male patient, 47 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, acute respiratory distress syndrome, aortic valve disease, cardiac failure acute, chills, condition aggravated, ejection fraction decreased, hypovolaemia, interstitial lung disease. Velcade dosage: 2.60 MG, UNK; INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FLECAINIDE ACETATE, FENOFIBRATE, ALLOPURINOL, BACTRIM, VALACYCLOVIR. Patient was hospitalized. Velcade Side Effects Report #5214194-1
Velcade side effect was reported by a Physician from UNITED STATES on Jan 03, 2007. Male patient, 82 years of age, weighting 173.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, chronic obstructive pulmonary disease, hyperlipidaemia, mental status changes, multiple myeloma , pancytopenia, renal failure acute, respiratory failure. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, ASCORBIC ACID. Patient was hospitalized. Patient died on 11/18/2006.Velcade Side Effects Report #5214325-3
Physician from UNITED STATES reported Velcade side effect on Dec 11, 2006. Male patient was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: dehydration, hypoxia, interstitial lung disease, lung infiltration, pyrexia, respiratory distress. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with INSULIN. Patient was hospitalized.
Velcade Side Effects Report #5214690-7
Velcade side effect was reported by a Physician from FRANCE on Jan 04, 2007. Male patient, 64 years of age, weighting 152.1 lb, was diagnosed with b-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: diffuse alveolar damage, herpes zoster, hypercalcaemia, interstitial lung disease, lung disorder, lung infection, malignant neoplasm progression, non-hodgkin's lymphoma. Velcade dosage: 2.90 MG, INTRAVENOUS. During the same period patient was treated with TINZAPARIN, RAMIPRIL, ALLOPURINOL. Patient was hospitalized.
Velcade Side Effects Report #5214696-8
Physician from BELGIUM reported Velcade side effect on Jan 04, 2007. Male patient, 56 years of age, weighting 204.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchitis , bursitis , lymphopenia, palmar-plantar erythrodysaesthesia syndrome. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXIL, TEGRETOL, CARDIO ASPIRINA, ZANTAC, DEXCHLORPHENIRAMINE MALEATE, LITICAN. Patient was hospitalized. Velcade Side Effects Report #5214702-0
Velcade side effect was reported by a Physician from GERMANY on Jan 11, 2007. Female patient, 76 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: multiple myeloma . Velcade dosage: 1.30 MG. Patient died on 11/12/2006.Showing 1-50 of 5712 Next >
63%